'Real-world' experience of colonic stents for obstructive colon cancer-feasible and safe with low morbidity and mortality
dc.contributor.author | Liptrot, S | |
dc.contributor.author | Singh, Rajeev | |
dc.contributor.author | Tou, Samson | |
dc.date.accessioned | 2018-01-23T14:25:39Z | |
dc.date.available | 2018-01-23T14:25:39Z | |
dc.date.issued | 2017-10 | |
dc.identifier.citation | Colorectal Disease; Oct 2017; vol. 19 ; p. 33 | en |
dc.identifier.uri | http://hdl.handle.net/20.500.12904/241 | |
dc.description | Author(s) Pre Print Version Only. 12 Month Embargo on Post Print. No PDF | en |
dc.description.abstract | Aim: To define the 'real-world' incidence of technical and clinical success, morbidity and mortality in consecutive patients undergoing self-expanding metallic stent (SEMS) implantation for obstructive colonic cancer. Method: Retrospective review of 163 patients undergoing SEMS at two centres (Royal Derby Hospital, UK and Chesterfield Royal Hospital, UK) between 2008 and 2016 cross-referenced with electronic databases for accuracy. Results: 163 patients received a total of 188 SEMS over a 99 month. The mean age was 72 (range 26-102). 82 (49.5%) presented with features of acute or sub-acute obstruction, 37 (22.7%) as a surgical emergency, 8 (5%) with fistulating tumors and 12 (7.4%) received SEMS as a bridge to semi-elective curative surgery. There were high rates of technical and clinical success (89% and 88% respectively) with a low overall incidence of complications (3.2%). Major complications included 2 (1.1%) early (<1 month) stent migrations, 4 (2.1%) perforations (day 0, 5 and 12) but no significant haemorrhage. Overall major complication rate of 6/188 (3.2%). Delayed stent migration (>1 month) occurred in 2 patient. Overall 10 procedures (6.1%) were abandoned for various reasons including that the lesion could not be crossed. Information on overall 30 day mortality (1/96, 1.04%) was available at Royal Derby Hospital. Conclusion: In this large 'real-world' case series SEMS was technically feasible with high levels of technical and clinical success and low 30-day morbidity and mortality. These results support the positive findings of randomised trials and the use of SEMS for palliation and in selected patients prior to staged surgical resection. | en |
dc.language.iso | en | en |
dc.subject | Self Expanding Metallic Stent | en |
dc.subject | SEMS | en |
dc.subject | Surgery | en |
dc.title | 'Real-world' experience of colonic stents for obstructive colon cancer-feasible and safe with low morbidity and mortality | en |
dc.type | Article | en |